BlackRock’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94K | Hold |
13,040
| – | – | ﹤0.01% | 4783 |
|
|
2025
Q1 | $108K | Sell |
13,040
-681
| -5% | -$5.62K | ﹤0.01% | 4704 |
|
|
2024
Q4 | $547K | Buy |
13,721
+4,654
| +51% | +$185K | ﹤0.01% | 4338 |
|
|
2024
Q3 | $78.5K | Sell |
9,067
-29
| -0.3% | -$251 | ﹤0.01% | 4669 |
|
|
2024
Q2 | $79.6K | Sell |
9,096
-3,054
| -25% | -$26.7K | ﹤0.01% | 4702 |
|
|
2024
Q1 | $298K | Buy |
12,150
+304
| +3% | +$7.45K | ﹤0.01% | 4443 |
|
|
2023
Q4 | $197K | Sell |
11,846
-32
| -0.3% | -$531 | ﹤0.01% | 4567 |
|
|
2023
Q3 | $222K | Sell |
11,878
-141
| -1% | -$2.63K | ﹤0.01% | 4582 |
|
|
2023
Q2 | $292K | Sell |
12,019
-285
| -2% | -$6.92K | ﹤0.01% | 4546 |
|
|
2023
Q1 | $269K | Buy |
12,304
+6
| +0% | +$131 | ﹤0.01% | 4617 |
|
|
2022
Q4 | $293K | Sell |
12,298
-8,404
| -41% | -$200K | ﹤0.01% | 4662 |
|
|
2022
Q3 | $569K | Sell |
20,702
-320
| -2% | -$8.8K | ﹤0.01% | 4593 |
|
|
2022
Q2 | $636K | Sell |
21,022
-43,019
| -67% | -$1.3M | ﹤0.01% | 4604 |
|
|
2022
Q1 | $3.44M | Buy |
64,041
+109
| +0.2% | +$5.86K | ﹤0.01% | 4065 |
|
|
2021
Q4 | $19M | Buy |
63,932
+14,350
| +29% | +$4.26M | ﹤0.01% | 3247 |
|
|
2021
Q3 | $19.2M | Buy |
49,582
+6,220
| +14% | +$2.41M | ﹤0.01% | 3253 |
|
|
2021
Q2 | $22.1M | Buy |
43,362
+15,527
| +56% | +$7.91M | ﹤0.01% | 3183 |
|
|
2021
Q1 | $15.8M | Buy |
27,835
+1,251
| +5% | +$711K | ﹤0.01% | 3252 |
|
|
2020
Q4 | $18.4M | Buy |
+26,584
| New | +$18.4M | ﹤0.01% | 2988 |
|